Stock listing

Resverlogix Corp.

Selected listing: RVX · NEO · CAD · CA

Resverlogix Corp. (Cboe Canada: RVX), Health Technology. Latest release Sep 10, 2026: Resverlogix Announces Publication of Scientific Journal Articles…

RVX:NEOCADCAUpdated October 2, 2026

Ticker: Cboe Canada: RVX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Cboe Canada
Currency: CAD

About Resverlogix Corp.

Resverlogix Corp. is a public company listed on the Canadian stock market under the ticker RVX. Resverlogix focuses on developing innovative therapies for chronic diseases, particularly in the area of cardiovascular health.

Latest news from Resverlogix Corp.

Resverlogix Announces Publication of Scientific Journal Articles Relating to Apabetalone's Prevention of Heart Failure

September 10, 2026

Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders

June 24, 2026

Resverlogix Closes US$2 Million Shares-for-Interest Private Placement

May 19, 2026

Resverlogix : Financial Statement Q1 2026

May 15, 2026

Resverlogix : MD&A Q1 2026

May 15, 2026

All Resverlogix Corp. news →

Research Resverlogix Corp.

Resverlogix Corp. company profile

View the public company page for Resverlogix Corp. on 6ix.

Resverlogix Corp. news

Read company news and market updates connected to Resverlogix Corp..

Resverlogix Corp. investor events

Find investor webinars, events, and replay context for Resverlogix Corp..